Tokio Marine Asset Management Co. Ltd. cut its stake in Balchem Co. (NASDAQ:BCPC – Free Report) by 13.9% in the third quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 3,100 shares of the basic materials company’s stock after selling 500 shares during the period. Tokio Marine Asset Management Co. Ltd.’s holdings in Balchem were worth $546,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
A number of other hedge funds and other institutional investors have also modified their holdings of BCPC. Envestnet Portfolio Solutions Inc. increased its position in shares of Balchem by 1.5% during the 2nd quarter. Envestnet Portfolio Solutions Inc. now owns 3,926 shares of the basic materials company’s stock worth $604,000 after purchasing an additional 59 shares during the last quarter. Inspire Investing LLC increased its position in shares of Balchem by 2.7% during the third quarter. Inspire Investing LLC now owns 2,348 shares of the basic materials company’s stock worth $413,000 after acquiring an additional 62 shares during the period. Hsbc Holdings PLC raised its position in Balchem by 1.5% in the 2nd quarter. Hsbc Holdings PLC now owns 4,915 shares of the basic materials company’s stock valued at $757,000 after purchasing an additional 75 shares in the last quarter. Atomi Financial Group Inc. raised its holdings in Balchem by 6.1% in the third quarter. Atomi Financial Group Inc. now owns 1,674 shares of the basic materials company’s stock valued at $295,000 after acquiring an additional 96 shares in the last quarter. Finally, Xponance Inc. raised its holdings in shares of Balchem by 5.2% in the 2nd quarter. Xponance Inc. now owns 2,046 shares of the basic materials company’s stock valued at $315,000 after purchasing an additional 102 shares in the last quarter. 87.91% of the stock is owned by institutional investors and hedge funds.
Analyst Ratings Changes
A number of equities analysts recently issued reports on BCPC shares. StockNews.com raised Balchem from a “hold” rating to a “buy” rating in a report on Monday, October 28th. HC Wainwright raised their price target on Balchem from $185.00 to $190.00 and gave the stock a “buy” rating in a report on Monday, November 4th.
Balchem Price Performance
Shares of BCPC opened at $177.77 on Friday. The company has a current ratio of 2.98, a quick ratio of 1.90 and a debt-to-equity ratio of 0.21. The stock’s 50 day moving average is $172.71 and its two-hundred day moving average is $165.59. Balchem Co. has a twelve month low of $120.76 and a twelve month high of $186.03. The firm has a market capitalization of $5.78 billion, a PE ratio of 47.79, a P/E/G ratio of 5.30 and a beta of 0.65.
Balchem Company Profile
Balchem Corporation develops, manufactures, and markets specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition, and industrial markets worldwide. It operates through three segments: Human Nutrition and Health, Animal Nutrition and Health, and Specialty Products.
Recommended Stories
- Five stocks we like better than Balchem
- Using the MarketBeat Dividend Yield Calculator
- ORIC: Working with Two Pharma Giants, Analysts See +100% Upside
- How to Use the MarketBeat Dividend Calculator
- Freeport-McMoRan, Copper Demand Short-Term Pain, Long-Term Gain
- The 3 Best Fintech Stocks to Buy Now
- Time to Load Up on Home Builders?
Want to see what other hedge funds are holding BCPC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Balchem Co. (NASDAQ:BCPC – Free Report).
Receive News & Ratings for Balchem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Balchem and related companies with MarketBeat.com's FREE daily email newsletter.